VistaGen Licenses Stem Cell Technology to New Firm Backed by Big Pharma – Jutia Group (press release) (blog)
|
VistaGen Licenses Stem Cell Technology to New Firm Backed by Big Pharma
Jutia Group (press release) (blog) VistaGen Therapeutics has granted an exclusive sublicense for its stem cell technologies to BlueRock Therapeutics, a new biotech backed by pharma heavyweight Bayer AG and venture capital firm Versant Ventures of San Francisco. The sublicense, for … |
